2024-05-09 16:09:20 ET
More on Pacific Biosciences of California
- Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership
- Pacific Biosciences of California, Inc. (PACB) Q4 2023 Earnings Call Transcript
- Why Is Pacific Biosciences' Price Action So Bad? (Downgrade)
- Pacific Biosciences of California Q1 2024 Earnings Preview
- PacBio moved to Neutral at JPMorgan after guidance cut
Read the full article on Seeking Alpha
For further details see:
Pacific Biosciences of California Non-GAAP EPS of -$0.26 in-line, revenue of $38.81M misses by $3.23M